Lifestyle Care for Fertility Outcome Evaluation
Launched by CHRISTINE KAISER, LAC, DACM · Feb 28, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Lifestyle Care for Fertility Outcome Evaluation is a clinical trial that aims to see how a specific program can help women facing fertility issues. This study is currently looking for participants who are between 18 and 50 years old, have a uterus, and are able to communicate in English. To join, women must be diagnosed with infertility and be currently participating in the Lifestyle Care for Fertility program. Unfortunately, those who are pregnant, younger than 18, older than 50, or have significant difficulties with sight, hearing, or understanding will not be able to participate.
If you are eligible and decide to take part in this trial, you can expect to share your experiences with the program and how it may be affecting your fertility journey. The study is in the recruiting phase, meaning they are actively looking for women to join. It’s a great opportunity to contribute to research that could help others in similar situations, and you’ll need to have an email address and a mobile device with a data plan to participate.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult with a uterus aged from 18 to 50 years
- • Participating in the Lifestyle Care for Fertility program
- • Able to speak and understand English.
- • Has email address and access to mobile device with a functioning data plan.
- • Infertility-related diagnosis
- Exclusion Criteria:
- • Age \< 18 or \> 50 years
- • Having a significant and uncorrected visual, hearing, or cognitive impairment
- • Inability to provide consent
- • Current pregnancy
About Christine Kaiser, Lac, Dacm
Christine Kaiser, LAc, DACM, is a distinguished clinical trial sponsor with a robust background in acupuncture and integrative medicine. With a Doctorate in Acupuncture and Chinese Medicine, she leads innovative research initiatives that explore the efficacy of alternative therapies in clinical settings. Her commitment to advancing evidence-based practices is complemented by her expertise in patient-centered care, aiming to enhance treatment outcomes through holistic approaches. Christine's dedication to fostering collaboration among healthcare professionals and researchers positions her as a pivotal figure in the realm of clinical trials focused on integrative health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Christine Kaiser, DACM LAc
Principal Investigator
University Hospitals Cleveland Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported